EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,218 | -53.7% | 20,064 | 0.0% | 0.00% | – |
| Q2 2023 | $147,470 | -26.3% | 20,064 | +3.9% | 0.00% | – |
| Q1 2023 | $200,000 | -12.3% | 19,305 | 0.0% | 0.00% | – |
| Q4 2022 | $227,992 | -43.7% | 19,305 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $405,212 | -32.4% | 19,305 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $599,000 | -24.5% | 19,305 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $793,000 | -4.6% | 19,305 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $831,000 | -63.1% | 19,100 | -57.5% | 0.00% | -60.0% |
| Q3 2021 | $2,250,000 | -21.9% | 44,950 | -1.8% | 0.01% | -16.7% |
| Q2 2021 | $2,882,000 | -5.9% | 45,754 | +38.7% | 0.01% | 0.0% |
| Q1 2021 | $3,064,000 | +7.5% | 32,982 | +3.7% | 0.01% | 0.0% |
| Q4 2020 | $2,851,000 | -3.0% | 31,819 | +11.8% | 0.01% | -14.3% |
| Q3 2020 | $2,940,000 | -81.1% | 28,452 | -85.6% | 0.01% | -80.6% |
| Q2 2020 | $15,584,000 | +21.2% | 197,075 | -11.3% | 0.04% | +2.9% |
| Q1 2020 | $12,858,000 | +2.7% | 222,232 | -4.2% | 0.04% | +34.6% |
| Q4 2019 | $12,515,000 | -39.2% | 231,979 | -41.1% | 0.03% | -42.2% |
| Q3 2019 | $20,580,000 | -6.5% | 393,646 | -13.6% | 0.04% | -4.3% |
| Q2 2019 | $22,002,000 | +9.5% | 455,430 | +14.5% | 0.05% | +4.4% |
| Q1 2019 | $20,087,000 | -8.2% | 397,616 | +7.7% | 0.04% | -16.7% |
| Q4 2018 | $21,878,000 | +578.6% | 369,070 | +653.7% | 0.05% | +671.4% |
| Q3 2018 | $3,224,000 | +9.8% | 48,971 | -15.8% | 0.01% | +16.7% |
| Q2 2018 | $2,935,000 | -1.0% | 58,140 | +3.3% | 0.01% | 0.0% |
| Q1 2018 | $2,964,000 | +26.3% | 56,305 | +11.5% | 0.01% | +20.0% |
| Q4 2017 | $2,347,000 | +78.6% | 50,497 | +55.5% | 0.01% | +66.7% |
| Q3 2017 | $1,314,000 | +48.6% | 32,477 | +24.6% | 0.00% | +50.0% |
| Q2 2017 | $884,000 | +2.6% | 26,073 | -12.1% | 0.00% | 0.0% |
| Q1 2017 | $862,000 | -49.5% | 29,675 | -42.9% | 0.00% | -50.0% |
| Q4 2016 | $1,707,000 | +2.4% | 51,981 | -1.7% | 0.00% | +33.3% |
| Q3 2016 | $1,667,000 | +35.5% | 52,855 | +20.8% | 0.00% | 0.0% |
| Q2 2016 | $1,230,000 | -1.2% | 43,755 | +27.8% | 0.00% | 0.0% |
| Q1 2016 | $1,245,000 | -46.6% | 34,240 | -41.3% | 0.00% | -50.0% |
| Q4 2015 | $2,332,000 | +40.4% | 58,295 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $1,661,000 | -18.7% | 58,295 | -6.0% | 0.00% | -20.0% |
| Q2 2015 | $2,044,000 | +10.8% | 62,038 | -3.3% | 0.01% | +25.0% |
| Q1 2015 | $1,845,000 | -30.3% | 64,137 | -34.0% | 0.00% | -33.3% |
| Q4 2014 | $2,648,000 | +27.8% | 97,233 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $2,072,000 | -13.5% | 97,233 | -8.8% | 0.01% | 0.0% |
| Q2 2014 | $2,395,000 | +28.4% | 106,654 | +44.5% | 0.01% | +25.0% |
| Q1 2014 | $1,865,000 | +82.3% | 73,791 | +65.8% | 0.00% | +100.0% |
| Q4 2013 | $1,023,000 | +20.6% | 44,497 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $848,000 | +32.1% | 44,497 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $642,000 | – | 44,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |